📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV). (2023)

First Author: Whiting D

Attributed to: A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjment-2022-300634

PubMed Identifier: 37316256

Publication URI: http://europepmc.org/abstract/MED/37316256

Type: Journal Article/Review

Volume: 26

Parent Publication: BMJ mental health

Issue: 1

ISSN: 2755-9734